Our Members
As a member-focused Association, our members are at the heart of everything we do at the PRI.
In principle any organization (public or private) is eligible to join the Association and become part of Europe’s growing microbiome-based medicinal product ecosystem.
Find out more about the different ways you and your organization can get involved with the PRI’s activities.
- Microbiome Regulatory Science Support Work
- Pre-competitive Task Groups
- Year-round networking and project-related communication support
More than 100 PRI Members from 24 countries represent nearly every point along the microbiome science and development continuum, from fundamental research groups all the way to commercial manufacturing partners and pharmaceutical companies.
Select Microbiome Activity Segment
- All segments
- Microbiome Product Developer
- Microbiome Analysis Expertise (service provider)
- Microbiome Pre-Clinical Research (CRO)
- Microbiome Clinical Research (CRO)
- Microbiome Contract Manufacturing Organization (CMO)
- Microbiome Contract Development & Manufacturing Organization (CDMO)
- Other Expertise | Quality, Legal, IP, Regulatory Affairs, Management
- Microbiome Research & Technology (public)
- Investment | Incubator | Accelerator | Tech Transfer
- Pharma (Human)
- Pharma (Veterinary)
- Diagnostics
- Consumer Goods
- News & Events
- PRI Publications
- PRI Member Job Openings
Select Country
5QBD-Biotech
Accelsiors AG
AcuraBio
Adiso therapeutics
ADM
Alveolus Bio
C. Vivek Lal
Founder & CEO
Pioneering breakthrough FDA-approved therapeutics for lung diseases. Our pipeline includes preclinical phase live biotherapeutics for Chronic Obstructive Pulmonary Disease (COPD), Lung Injury Secondary to Viral Illness, Bronchopulmonary Dysplasia (BPD), Neutrophilic Asthma, and earlier stage programs, including Pulmonary Arterial Hypertension (PAH), Acute Respiratory Distress Syndrome, and Idiopathic Pulmonary Fibrosis.
Animalcare Ltd.
Aptar CSP Technologies
Ardigen
Janusz Homa
CEO
We strongly believe that the future of healthcare is in Precision Medicine, in which physicians are guided by Artificial Intelligence. We pursue this vision. People First - that’s how we think. Everything we do is for the betterment of human life. Ardigen’s success depends on our team’s potential and passion.
Arranta Bio
Melanie Cerullo
Chief Quality & Regulatory Officer
Arranta Bio provides novel solutions to clients for advanced therapy process development and manufacturing. Our expertise and ability to provide end-to-end solutions helps guide advanced therapeutic products through the clinical journey to the commercial. We focus on partnership and tailor our solutions to each company’s unique needs.
Astel Medica
Nail Nasir
Scientific Manager
Astel Medica is a fast growing belgian pharmaceutical company. Founded in 1988 with the collaboration of the University of Liège, Astel Medica is the Belgian leader in the conception and manufacturing of innovative evidence based symbiotics. Working in collaboration with 7 universities, Astel Medica invests in Research and Development as to provide the best Probiotics on the market.
Atlantia Clinical Trials
BaseClear BV
Radhika Bongoni
Commercial Director
Founded in 1993, we are a pioneer on the market and have been on the forefront of the microbial genomics revolution. We are the preferred partner for many leading brands in various industries such as human health, personal care and animal nutrition in the Netherlands, in Europe and beyond. We support our clients in improving their processes and products, gaining approval and confirming claims.
Bio-Me AS
BIOASTER
Biofortis
Biomeostasis
Biomica
Biose Industrie
Richard Ellis
Business Development
Founded in 1951 by pharmacists and microbiologists, biose® industrie has 70-years experience in drugs based on live bacteria, giving us a deep understanding of the entire process from discovery to commercialization. Focused on Health through microbiota and microbiome science, we use our skills for the discovery, product development, clinical studies and manufacturing of Live Biotherapeutic Products (LBP). Our company is drug-GMP certified for the manufacturing of bacteria-based Drug Substance and Drug Product for clinical and commercial applications.
Boehringer Ingelheim
Anne Cadoux
Head of Regulatory Affairs Animal Health Care Products
Boehringer Ingelheim Animal Health France is born from Merial in 2018 further to the acquisition of Merial by Boehringer Ingelheim, a large pharmaceutical company with a small Animal Health department. Now 2nd biggest company in the world for Animal Health products. Innovation is one of its characteristics.
BoobyBiome
Lydia Mapstone
Co-Founder & CEO
BoobyBiome, a female-led UK-micro SME, is developing a rationally-designed live biotherapeutic product (LBP) tailored for babies with compromised microbiomes. Informed by rigorous scientific testing and precise characterisation of breast milk, the LBP will replenish the infant gut to a healthier state.
Boston Analytical
Nicole Olivieri
Marketing Event Manager
Boston Analytical specializes in providing high-quality analytical testing services for the CMC (Chemistry, Manufacturing and Controls) parameters involved in drug development and release testing. Our cGMP, FDA registered analytical testing laboratory is equipped to conduct all relevant testing and related services, including analytical development, storage and stability testing and microbiology testing.
Caelus Health
Luc Sterkman
CEO
Caelus Health is an Amsterdam-based biotech company with in-depth knowledge of the microbiome, dedicated to the development and commercialization of microbiota-based products to prevent and treat cardiometabolic disorders, including Diabetes, and other unmet medical needs. The company has built a strong patented-protected proprietary position for the treatment of Diabetes Mellitus Type 1 and Type 2, cancer cachexia and auto-immune diseases.
Chr. Hansen A/S
Clinical Microbiomics
CommBio Therapeutics
CosmosID
Mo Langhi
Director, Business Development
CosmosID® is a global leader in supporting the pharmaceutical sector with CLIA-certified, ICH-GCP compliant microbiome and microbial isolate solutions for applications such as pre-clinical, clinical, CMC and regulatory support. In addition to Next Generation Sequencing workflows, CosmosID also offers validated, industry-leading bioinformatics, yielding multi-kingdom, strain-level resolution with leading sensitivity and precision.
CPS Research
Alan Wade
Director
CPS Research is an independent clinical research site located in Glasgow, Scotland. Established in 1988, we conduct clinical trials in Phases II to IV in Pharmaceuticals, Food Supplements, Medical Devices and Over the Counter (OTC) therapies. We offer a personalised service to a worldwide client base of both large and small pharmaceutical, biotech and food organisations. Our single tier management structure allows an easy flow of communication with our clients.
Cryptobiotix
DestinyPharma
DNA Genotek Inc.
Héloïse Breton
Sr. Product Manager, Microbiome & Metabolomics
Don Whitley Scientific Limited
Eagle Genomics
Eligo Bioscience
EnteroBiotix
ENTEROSYS
EverImmune
Ferring Pharmaceuticals
Ferryx
GMT Science
Hallym University
Suenie Park
Professor
Hallym University is a four-year private university set at the foot of Bong Ui Mountain in central Chuncheon. Since its foundation in 1982, the university has strived to nurture its students into leaders of tomorrow. Located one-hour east of Seoul and served by world class transportation links, Chuncheon serves as the gateway as well as the capital of the province of Gangwon-do.
Hospital-ASST Bergamo Est
ICO
ICOSA
IFF
INRAE
Patrick Veiga
Gut Microbiome & Nutrition Research Research Director
INRAE is committed to exploring the frontiers of science and performing high-calibre research that is globally relevant. The institute makes major contributions to European research and participates in European research programmes (e.g., via research networks, H2020 research projects, Marie Skłodowska-Curie Actions) and, as a result, is currently developing bilateral and trilateral partnerships. Our international collaborations focus on sharing laboratories or infrastructure, becoming integrated into research networks, and playing a role within international organisations.
INRAE Transfert Genome and Transcriptome
Institut Pasteur Lille France
Catherine DANIEL
Principal Investigator, Senior Researcher
Cancers, infectious diseases (COVID-19, tuberculosis, whooping cough, etc.), cardiovascular diseases, Alzheimer's disease, inflammatory diseases, diabetes, ...34 research teams are working every day to understand and fight against these diseases, to slow their development, to imagine tomorrow's treatments and to change behavior.
Invitek Molecular GmbH
Lactosan GmbH
Lallemand Health Solutions
Mbiomics Gmbh
Microba Life Sciences
Microbiotica
Milmed Unico AB
Tomas Lenz
CEO
We are an developer of Live Biotherapeutic Products. After 14 years of research the main objective is our development of regulated human LBP for treatment of allergic disorders, neurodegenerative diseases and inflammatory diseases. Our research and work has been rewarded, thus far, with two approved patents and a third patent pending to add to our growing patent family.
MRM Health NV
MyBiotics Pharma Ltd.
Neobe Therapeutics
NeoBioSys
Nestlé Health Science
Nexbiome Therapeutics
NIZO
Orion Corporation Orion Pharma R&D
PharmaBiome AG
PiLeje
POSTECH
Sin-hyeog Im
Professor
Probiotical Research
Marco Pane
R&D Director
Probiotical is an Italian family-owned company specialized since 1985 in probiotics manufacture, from the raw material to the finished products, with very high quality, guaranteed stability and scientifically backed strains. We are driving innovation in a variety of functionalities and technologies.
ProDigest BV
PROGE FARM S.r.l.
Quadram Institute
Recolony
Seres Therapeutics, Inc.
Ann Kurowski
Vice President Regulatory Affairs
Seventure Partners
Isabelle de Cremoux
CEO & Managing Partner
SGS Quay Pharma
Michael Kruidenier
Head of BD
No other CDMO has the breadth of knowledge in the formulation services we offer, our clinical trials manufacturing and supply know how as well as our specialist knowledge in providing cost efficient engineering solutions to meet the many challenges that we know can accompany the finished product manufacture of microbial therapies.
Siolta Therapeutics
SkinBiotherapeutics PLC
SMALTIS
Spanish National Research Council (IATA-CSIC)
TargEDys
The BioArte
Univ Beira Intérior
Ana Palmeira-de-Oliveira
Invited Professor
The University of Beira Interior (UBI), is a Portuguese institution of higher education in expansion, reaching the status of academy, which welcomes students from all regions of the country and international students from dozens of nationalities, namely from Portuguese-speaking countries and Latin America.
Université Grenoble alpes
University College Cork
University of Ghent
Tom Van de Wiele
Full Professor
University of Queensland Australia
Anders Cervin
Professor
The University of Queensland (UQ) is one of Australia’s leading research and teaching institutions. We strive for excellence through the creation, preservation, transfer and application of knowledge. For more than a century, we have educated and worked with outstanding people to deliver knowledge leadership for a better world.